AdaptHealth CFO granted 141K RSUs in 2026

AdaptHealth’s chief financial officer received a compensation grant of 141,372 restricted stock units that will settle in common stock upon vesting.

Rhea-AI Filing Summary

AdaptHealth Corp. (symbol: AHCO) is the issuer of record for a Form 4 filing submitted to the SEC. CURRIE HARRISS T reported acquisition or exercise transactions in this Form 4 filing.

AdaptHealth Corp. (AHCO) reported that its Chief Financial Officer, Harriss T. Currie, received a grant of 141,372 shares of Common Stock in the form of restricted stock units on September 9, 2026. These restricted stock units will be settled in common stock upon vesting, and Currie now directly holds 141,372 shares. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Grant/Award: 141,372 shares

Grant/Award 1 txn

Insider CURRIE HARRISS T

Role CHIEF FINANCIAL OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	141,372	$0.00	$0.00

Holdings After Transaction: Common Stock — 141,372 shares (Direct)

Footnotes (1)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Key Figures

Restricted stock units granted: 141,372 shares Grant price per share: $0.00 per share Shares held after transaction: 141,372 shares

3 metrics

Restricted stock units granted 141,372 shares Grant to Chief Financial Officer on September 9, 2026

Grant price per share $0.00 per share Compensation grant of restricted stock units

Shares held after transaction 141,372 shares Direct holdings of Chief Financial Officer after the grant

Key Terms

restricted stock units, Power of Attorney, Form 3

3 terms

restricted stock units financial

"These shares represent restricted stock units and will be settled"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Power of Attorney regulatory

"The Power of Attorney given by the reporting person was previously filed"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

Form 3 regulatory

"filed with the U.S. Securities and Exchange Commission on September 11, 2026 as an exhibit to the Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth Corp. (AHCO) report in this Form 4?

AdaptHealth reported that its Chief Financial Officer, Harriss T. Currie, received a grant of 141,372 restricted stock units of Common Stock on September 9, 2026, classified as a grant, award, or other acquisition.

How many AdaptHealth (AHCO) shares does the CFO hold after this transaction?

After the reported grant, Chief Financial Officer Harriss T. Currie directly holds 141,372 shares of AdaptHealth Common Stock, corresponding to the restricted stock units reported in the filing.

Was the AdaptHealth (AHCO) CFO’s equity grant made under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the September 9, 2026 grant was made pursuant to a Rule 10b5-1 trading plan.

What type of security did the AdaptHealth (AHCO) CFO receive in this Form 4?

The Chief Financial Officer received restricted stock units that will be settled in AdaptHealth Common Stock upon vesting, as explained in the transaction footnote.

At what price were the AdaptHealth (AHCO) restricted stock units granted to the CFO?

The reported price per share for the grant is $0.00, which is typical for equity compensation awards such as restricted stock units, reflecting that this was a compensation grant rather than a market purchase.

Does the Form 4 mention any prior Power of Attorney for the AdaptHealth (AHCO) CFO?

Yes. The filing states that a Power of Attorney for the reporting person was previously filed on September 11, 2026 as an exhibit to the Form 3 relating to AdaptHealth and is incorporated by reference.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 04:12 PM Accepted by SEC EDGAR 09/11/2026 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CURRIE HARRISS T

(Last) (First) (Middle)

C/O ADAPTHEALTH CORP.

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		A		141,372(1)	A	$0	141,372	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on September 11, 2026 as an exhibit to the Form 3 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Harriss T. Currie	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)